davidulmert Profile Banner
davidulmert Profile
davidulmert

@davidulmert

Followers
75
Following
347
Media
0
Statuses
76

Director, Preclinical Theranostics Program at UCLA. Parka monkey. Tweets are my own.

California, USA
Joined September 2014
Don't wanna be here? Send us removal request.
@davidulmert
davidulmert
1 month
RT @Larvol: Human kallikrein 2 (encoded by the KLK2 gene; KLK2) is a novel target expressed in prostate cancer cells. KLK2 pipeline — from….
0
12
0
@davidulmert
davidulmert
1 month
RT @MikeSerzanMD: 🗣️Prostate Rapid Oral Abstract #ASCO25. 👉Abst5017: Dr #CapucineBaldini .presenting #Pasritamig in mCRPC. 🔑 KEY TAKE AWAYS….
0
8
0
@davidulmert
davidulmert
1 month
RT @jordanciuro: 🔎Phase 1 results of JNJ-78278343 (pasritamig) in mCRPC? A first in class bispecific T-cell engager targeting human kallikr….
0
5
0
@davidulmert
davidulmert
1 month
RT @MAWildgust: Excited to share the first results from our ⁦@JNJInnovation⁩ new KLK2xCD3 investigational agent called pasritamig, a first-….
0
8
0
@davidulmert
davidulmert
1 month
RT @MAWildgust: Oral presentation here @ASCO #ASCO25 describing a new target and mechanism in Prostate Cancer. #MyCompany .
0
2
0
@davidulmert
davidulmert
1 month
RT @DrChoueiri: 📢 #ASCO25 | mCRPC Ph. I | KLK2×CD3 bispecific pasritamig: First-in-human (n = 174) shows PSA50 42.4%, median rPFS 6.8 m; G≥….
0
16
0
@davidulmert
davidulmert
1 year
RT @urotoday: A phase 1 study of JNJ-69086420 (JNJ-6420), an actinium-225 (225Ac)-labeled antibody targeting human kallikrein 2, for #mCRPC….
0
8
0
@davidulmert
davidulmert
2 years
RT @visegrad24: There have been calls by some Muslim leaders to boycott Jewish products in solidarity with Palestine! . We would like to he….
0
6K
0
@davidulmert
davidulmert
2 years
RT @MagnusRanstorp: Den talande tystnaden är öronbedövande. Den antisemitism som blottat sig i samhället är skrämmande. Fler behöver träda….
0
813
0
@davidulmert
davidulmert
2 years
RT @SyedAAhmad5: The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovar….
0
8
0
@davidulmert
davidulmert
2 years
RT @brookmans76: EBRT increased AR pathway activity + [89Zr]11B6 uptake in PC bearing mice + [89Zr]11B6 uptake correlated with #hK2 protein….
0
2
0
@davidulmert
davidulmert
2 years
RT @brookmans76: [89Zr]11B6-#PET imaging as a potential tool to monitor treatment response in #ProstateCancer: @davidulmert et al. show tha….
0
3
0
@davidulmert
davidulmert
2 years
Exciting news! Our article on utilizing hK2-PET (89Zr-11B6) to assess AR-activity in PCa post external beam irradiation is now published in MCR as the cover story! Big thanks to the editorial team and associate editor @adscheid33 for their support:
1
0
7
@davidulmert
davidulmert
2 years
RT @MCR_AACR: Read our April Issue:.
Tweet media one
0
2
0
@davidulmert
davidulmert
3 years
RT @AgentsMIB: Excellent primer written by some of the best in osteosarcoma, including our own Scientific Advisory Board Members, @janeway_….
0
5
0
@davidulmert
davidulmert
3 years
RT @neerajaiims: #DAVABanffGU @OMIonc Enjoyed the wonderful talk by @PBarataMD @cwru on novel alpha therapy with Actinium-225, targeting a….
0
17
0
@davidulmert
davidulmert
3 years
RT @Butlerlab_UCLA: Please RT! @UCLAstemcell is recruiting multiple faculty positions, for any area of stem cell research and regenerative….
0
35
0
@davidulmert
davidulmert
3 years
RT @Uromigos: 🧵#UromigosLive: Emerging Actinium-225 alpha targeted radioligand therapy for advanced #ProstateCancer. Watch LIVE discussion….
0
4
0
@davidulmert
davidulmert
3 years
RT @proactive_au: $RAD Radiopharm Theranostics welcomes proof of concept for LRRC15 tumour targeting from prestigious scientific journal pu….
0
5
0
@davidulmert
davidulmert
3 years
RT @TeamRadioPharm: We are pleased to announce Dr. Shannon J. Turley & her team of more than 30 scientists published an authoritative analy….
0
2
0